ATE98869T1 - Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung. - Google Patents

Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.

Info

Publication number
ATE98869T1
ATE98869T1 AT89906213T AT89906213T ATE98869T1 AT E98869 T1 ATE98869 T1 AT E98869T1 AT 89906213 T AT89906213 T AT 89906213T AT 89906213 T AT89906213 T AT 89906213T AT E98869 T1 ATE98869 T1 AT E98869T1
Authority
AT
Austria
Prior art keywords
subjected
preparation
treatment
pharmaceutical agent
human cancer
Prior art date
Application number
AT89906213T
Other languages
English (en)
Inventor
Kuslima Shogen
Stanislaw M Mikulski
Wojciech J Ardelt
Original Assignee
Alfacell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfacell Corp filed Critical Alfacell Corp
Application granted granted Critical
Publication of ATE98869T1 publication Critical patent/ATE98869T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89906213T 1988-04-06 1989-03-31 Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung. ATE98869T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/178,118 US4882421A (en) 1982-09-23 1988-04-06 Pharmaceutical for treating tumors and method for making it
PCT/US1989/001357 WO1989009606A1 (en) 1982-09-23 1989-03-31 Pharmaceutical for treating tumors in humans and method for making it
EP89906213A EP0440633B1 (de) 1988-04-06 1989-03-31 Pharmazeutisches mittel für behandlung von menschlichem krebs und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
ATE98869T1 true ATE98869T1 (de) 1994-01-15

Family

ID=22651277

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906213T ATE98869T1 (de) 1988-04-06 1989-03-31 Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.

Country Status (6)

Country Link
US (1) US4882421A (de)
EP (1) EP0440633B1 (de)
JP (1) JPH03503530A (de)
AT (1) ATE98869T1 (de)
DE (1) DE68911693T2 (de)
WO (1) WO1989009606A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540925A (en) * 1988-04-06 1996-07-30 Alfacell Corporation Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
US5595734A (en) * 1988-04-06 1997-01-21 Alfacell Corporation Compositions comprising ONCONASE (tm) and lovastatin
US5728805A (en) * 1988-04-06 1998-03-17 Alfacell Corp. Pharmaceuticals and method for making them
US5529775A (en) * 1988-04-06 1996-06-25 Alfacell Corporation Compositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HCl
US5559212A (en) * 1988-04-06 1996-09-24 Alfacell Corporation Frog embryo and egg-derived tumor cell anti-proliferation protein
DE69006741T2 (de) * 1989-11-13 1994-06-01 Alfacell Corp Reines protein und bioaktive pharmazeutische produkte.
HU221407B1 (hu) * 1997-03-28 2002-09-28 Gyula Magvasi Ektodermális eredetû szövetekben fellépõ tumoros burjánzást gátló hatóanyag és készítmény, valamint eljárás elõállításukra
US6239257B1 (en) * 1998-12-30 2001-05-29 Alfacell Corporation Family of proteins belonging to the pancreatic ribonuclease a superfamily
RU2240810C2 (ru) * 2002-01-30 2004-11-27 Левон Никитович Мкртчян Эмбриональный противоопухолевый модулятор мкртчяна, способ его получения и применения
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
US9919034B2 (en) 2014-03-28 2018-03-20 Tamir Biotechnology, Inc. Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
US10835598B2 (en) 2014-08-18 2020-11-17 Orgenesis Inc. Prophylactic protection against viral infections, particularly HIV
SG10201911292SA (en) 2015-06-15 2020-02-27 Tamir Biotechnology Inc Pharmaceuticals for treatment of viral infections of the eye

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356426A1 (fr) * 1976-06-29 1978-01-27 Truffier Jean Claude Fraction ovomucoide du blanc de l'oeuf de caille, ayant des proprietes antiproteasiques
FR2489690A1 (fr) * 1979-05-07 1982-03-12 Coturnix Procede d'obtention de la fraction ovomucoide et d'un extrait d'ovomucoide de l'oeuf de caille, produits ainsi obtenus et leur application a titre de medicament

Also Published As

Publication number Publication date
US4882421A (en) 1989-11-21
EP0440633A1 (de) 1991-08-14
DE68911693T2 (de) 1994-05-11
JPH03503530A (ja) 1991-08-08
EP0440633B1 (de) 1993-12-22
DE68911693D1 (de) 1994-02-03
WO1989009606A1 (en) 1989-10-19

Similar Documents

Publication Publication Date Title
Lepage et al. Purification and characterization of the sea urchin embryo hatching enzyme
ATE98869T1 (de) Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.
BR0015506A (pt) Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
Pickart et al. [28] Biological activity of human plasma copper-binding growth factor glycyl-l-histidyl-l-lysine
ES8503941A1 (es) Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados
ATE203997T1 (de) Antiwachstumwirksame proteine aus oozyten von rana pipiens
JPH11501055A (ja) 真珠層を含む組成物の新規な使用
Trainin et al. Some characteristics of a thymic humoral factor determined by assay in vivo of DNA synthesis in lymph nodes of thymectomized mice
EP0220453A3 (en) Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
Shulman et al. Protein–polysaccharide of chicken cartilage and chondrocyte cell cultures
Abu-Samra et al. The inoculation of rabbits with Dermatophilus congolensis and the simultaneous infection of sheep with D. congolensis and orf virus
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
Kano‐Sueoka et al. Growth stimulating activity in bovine pituitary extract specific for a rat mammary carcinoma cell line
GB1038415A (en) Cosmetic preparations containing albumins
DE2034118A1 (en) Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
Tu et al. Comparison of Naja naja siamensis and Naja naja atra venoms
ATE101621T1 (de) Reines protein und bioaktive pharmazeutische produkte.
Matoušek Antiembryonic effect of bull seminal vesicle fluid in mice
JPS62116519A (ja) 人胎盤抽出細胞代謝活性化物質
GB2003887A (en) Isolation of peptides from urine
Fabiny Effects of versene and β‐2‐thienylalanine on the developing down feather
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
Larjava Effect of human dental bacterial plaque extract on the connective tissue of indashvitro cultured fetal rat calvaria
TWI664973B (zh) 荷葉萃取物用於治療色素沉積綜合症之用途

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time